Program
Register
Meeting Coverage
Guidelines
Industry Highlights
Science & Technology Hall
Meeting Coverage
Medical guidelines and recommendations take center stage at AUA2023
Optimizing patient outcomes with scientific evidence, including Dr. Neal D. Shore’s practice-changing data in prostate cancer.
Meeting Coverage
Genetic testing key to targeting prostate cancer
Meeting Coverage
Putting AUA Guidelines into practice
Meeting Coverage
Managing upper tract urothelial carcinoma in the real world
Guidelines
Don’t miss these guideline-driven sessions at AUA2023
Guidelines
AUA is your source for Guidelines at a Glance
The most up-to-date resources at the click of a button.
AUA2022
AUA details updated priapism guideline
The 2022 update is the first change to the guideline in more than two decades.
Sponsored
Check out the AUA’s brand new Gold Open Access journal,
JU Open Plus
All articles are freely accessible globally. Consider submitting your important research to this peer-reviewed journal today!
AUA2022
Updated guidelines improve management of renal masses
The revised guidelines include expanded indications for genetic counseling and address adjuvant therapy for the first time.
AUA2022
New update to clinically localized prostate cancer guidelines
Active surveillance has emerged as the preferred approach for low-risk prostate cancer.
AUA2021
New approaches to metastatic hormone-sensitive prostate cancer, castration-resistant prostate cancer
It is imperative for all clinicians to keep current in this rapidly changing field.
AUA2021
Tips and tricks for managing refractory overactive bladder
Third-line therapies continue to evolve to improve symptoms and patients’ quality of life.
AUA2021
Update on amended AUA/Society of Urologic Oncology joint guideline for NMIBC
Updated guideline offers new diagnostic choices and treatment options.
AUA2021
AUA updates guidelines for treating advanced prostate cancer
New therapies and imaging modalities continue to evolve.
AUA2021
New practice guidelines for localized renal masses
The new guidelines reflect important changes to the evaluation and management of localized renal masses.